Dose Optimization of Rivaroxaban in Elderly Chinese Patients with Non-Valvular Atrial Fibrillation: Analysis of Populations Pharmacokinetics and Exposure-Response Relationships

Li TY, Liu X, Tang L, Cai W, Zhang J, Su Y, Yu C, Liu BJ, Jiang LF, Liu C, Yu YX

Drug Design, Development and Therapy 2025, 19:10703-10717

Published Date: 3 December 2025